MAYNE PHARMA GROUP LIMITED - Announcements

Market Cap $391.3M Add to my watchlist

Healthcare

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

RCE'S BREAKTHROUGH

Synthetic anti-infective developer Recce Pharmaceuticals Ltd (ASX:RCE) has made inroads for recognition of its RECCE® 327 Gel (or R327G) as a topical treatment for burn wound infections, gaining a US$2 million grant from the US Department of Defense...

Announcements

Filter Results

All Price Sensitive Only

MYX	Change of Director's Interest Notice		17/03/17	597.55KB	Share
MYX	Ceasing to be a substantial holder		13/03/17	153.53KB	Share
MYX	Becoming a substantial holder		09/03/17	268.11KB	Share
MYX	Mayne Pharma appoints new Group CFO and Company Secretary		09/03/17	248.49KB	Share
MYX	Mayne Pharma acquires rights to generic Duragesic in the US	PRICE SENSITIVE	09/03/17	268.96KB	Share
MYX	Change of Director's Interest Notice		08/03/17	596.18KB	Share
MYX	Appendix 3B		06/03/17	724.44KB	Share
MYX	License and supply agreement for generic Nuvaring in the US	PRICE SENSITIVE	28/02/17	103.27KB	Share
MYX	2017 Half Year Investor Presentation		24/02/17	1.79MB	Share
MYX	2017 Half Year Media Release	PRICE SENSITIVE	24/02/17	312.52KB	Share
MYX	Half Yearly Report and Accounts	PRICE SENSITIVE	24/02/17	1.35MB	Share
MYX	Appendix 3B		20/02/17	731.15KB	Share
MYX	Mayne Pharma launches Butalbital / APAP tablets in the US	PRICE SENSITIVE	16/02/17	246.53KB	Share
MYX	Mayne Pharma announces leadership changes		16/01/17	106.72KB	Share
MYX	Mayne Pharma launches Amiodarone 100mg tablets	PRICE SENSITIVE	13/01/17	95.19KB	Share
MYX	Appendix 3B		12/01/17	316.47KB	Share
MYX	Change of Director's Interest Notice		11/01/17	946.66KB	Share
MYX	Mayne Pharma launches Fabior and Sorilux in the US	PRICE SENSITIVE	11/01/17	271.31KB	Share
MYX	Appendix 3B		28/12/16	324.18KB	Share
MYX	Change of Director's Interest Notice		28/12/16	41.9KB	Share
MYX	Change of Director's Interest Notice (x4)		21/12/16	1.95MB	Share
MYX	Appendix 3B		21/12/16	729.25KB	Share
MYX	Change in substantial holding from CBA		21/12/16	537.19KB	Share
MYX	Change of Director's Interest Notices (x2)		19/12/16	1.14MB	Share
MYX	Update on Status of DOJ Investigation	PRICE SENSITIVE	16/12/16	229.2KB	Share
MYX	Change in substantial holding from CBA		13/12/16	1.1MB	Share
MYX	Appendix 3B		13/12/16	731.24KB	Share
MYX	Change in substantial holding		12/12/16	75.12KB	Share
MYX	Change of Director's Interest Notice		12/12/16	49.22KB	Share
MYX	Ceasing to be a substantial holder from NAB		12/12/16	173.67KB	Share
MYX	Appendix 3B		09/12/16	325.25KB	Share
MYX	Change of Director's Interest Notice		07/12/16	41.47KB	Share
MYX	Becoming a substantial holder from NAB		30/11/16	564.37KB	Share
MYX	Results of Annual General Meeting		29/11/16	241.06KB	Share
MYX	2016 AGM CEO's Speech		29/11/16	209.38KB	Share
MYX	2016 AGM Chairman's Speech		29/11/16	183.9KB	Share
MYX	IDT:Mayne Pharma Announces U.S. Launch of IDT's Temozolomide		22/11/16	536.47KB	Share
MYX	UBS Australasia Conference Presentation		07/11/16	1.47MB	Share
MYX	Update on Status of DOJ Investigation	PRICE SENSITIVE	04/11/16	98.15KB	Share
MYX	MYX launches generic MS Contin (morphine sulfate) tablets-MYX.AX	PRICE SENSITIVE	03/11/16	108.48KB	Share
MYX	MYX launches generic MS Contin (morphine sulfate) tablets	PRICE SENSITIVE	03/11/16	108.48KB	Share
MYX	1st generic proprietary product shipped to US, temozolomide,MYX-IDT.AX	PRICE SENSITIVE	02/11/16	128.48KB	Share
MYX	Becoming a substantial holder from CBA,CBA-MYX.AX		01/11/16	1.18MB	Share
MYX	MYX launches generic Entocort EC (Budesonide) capsules-MYX.AX	PRICE SENSITIVE	27/10/16	101.92KB	Share
MYX	Notice of Annual General Meeting/Proxy Form-MYX.AX		17/10/16	2.62MB	Share
MYX	Appendix 3B-MYX.AX		11/10/16	480.48KB	Share
MYX	Appendix 4G-MYX.AX		07/10/16	327.05KB	Share
MYX	2016 Corporate Governance Statement-MYX.AX		07/10/16	395.82KB	Share
MYX	2016 Annual Report-MYX.AX		07/10/16	3.03MB	Share
MYX	Appendix 3B-MYX.AX		29/09/16	479.28KB	Share
MYX	Ceasing to be a substantial holder from WBC,WBC-MYX.AX		28/09/16	348.18KB	Share
MYX	Appendix 3B-MYX.AX		26/09/16	481.27KB	Share
MYX	Change of Director's Interest Notice-MYX.AX		23/09/16	108.49KB	Share
MYX	Initial Director's Interest Notice-MYX.AX		23/09/16	94.56KB	Share
MYX	Mayne Pharma appoints new Board member-MYX.AX		21/09/16	184.86KB	Share
MYX	Change of Director's Interest Notice-MYX.AX		13/09/16	386.46KB	Share
MYX	Change in substantial holding from WBC,WBC-MYX.AX		01/09/16	695.24KB	Share
MYX	Appendix 3B-MYX.AX		28/08/16	480.33KB	Share
MYX	2016 Full Year Results Investor Presentation-MYX.AX		28/08/16	1.2MB	Share
MYX	Appendix 4E, Directors Report and Financial Statements-MYX.AX	PRICE SENSITIVE	28/08/16	1.58MB	Share
MYX	2016 Full Year Results Media Release-MYX.AX		28/08/16	238.39KB	Share
MYX	2016 Full Year Results Investor Presentation-MYX.AX		26/08/16	1.2MB	Share
MYX	2016 Full Year Results Media Release-MYX.AX		26/08/16	238.39KB	Share
MYX	Appendix 4E, Directors Report and Financial Statements-MYX.AX	PRICE SENSITIVE	26/08/16	1.58MB	Share
MYX	Appendix 3B-MYX.AX		25/08/16	480.33KB	Share
MYX	Appendix 3B-MYX.AX		22/08/16	479.35KB	Share
MYX	Response to ASX Appendix 3Y Query-MYX.AX		19/08/16	718.83KB	Share
MYX	Investor Presentation Acquisition of GSK Foam Assets-MYX.AX		18/08/16	855KB	Share
MYX	MYX announces acquisition of US foam dermatology assets-MYX.AX	PRICE SENSITIVE	18/08/16	140.14KB	Share
MYX	Change of Director's Interest Notice-MYX.AX		16/08/16	312.71KB	Share
MYX	Appendix 3B-MYX.AX		11/08/16	479.24KB	Share
MYX	Appendix 3B-MYX.AX		04/08/16	478.99KB	Share
MYX	Completion of US generic product acquisition from Teva-MYX.AX		03/08/16	107.77KB	Share
MYX	MYX announces settlement from patent infringement case-MYX.AX	PRICE SENSITIVE	29/07/16	97.53KB	Share
MYX	Change in substantial holding from WBC,WBC-MYX.AX		27/07/16		Share
MYX	Change in substantial holding from WBC,WBC-MYX.AX		27/07/16	1.6MB	Share
MYX	Change of Director's Interest Notice-MYX.AX		27/07/16	425.38KB	Share
MYX	Ceasing to be a substantial holder from BTT,BTT-MYX.AX		26/07/16		Share
MYX	Ceasing to be a substantial holder from BTT,BTT-MYX.AX		26/07/16	176.78KB	Share
MYX	Appendix 3B-MYX.AX		22/07/16	352.25KB	Share
MYX	Change in substantial holding from BTT,BTT-MYX.AX		21/07/16		Share
MYX	Change in substantial holding from BTT,BTT-MYX.AX		21/07/16	198.9KB	Share
MYX	Retail Entitlement Offer completion and scale back policy-MYX.AX		20/07/16	239.63KB	Share
MYX	Change to option exercise price and Appendix 3B-MYX.AX		15/07/16	914.55KB	Share
MYX	Change of Director's Interest Notice-MYX.AX		13/07/16	386.6KB	Share
MYX	Change of Director's Interest Notices (x5)-MYX.AX		07/07/16	921.63KB	Share
MYX	Section 708A notice-MYX.AX		07/07/16	296.85KB	Share
MYX	ASX Notice - Accelerated Non Renounceable Entitlement Offer-MYX.AX		06/07/16	364.28KB	Share
MYX	Dispatch Retail Offer Booklet and ineligible letter-MYX.AX		05/07/16	404.39KB	Share
MYX	Retail Offer Booklet-MYX.AX		30/06/16	6.74MB	Share
MYX	Completion institutional entitlement offer and placement-MYX.AX	PRICE SENSITIVE	30/06/16	282.55KB	Share
MYX	Investor Presentation Acquisition of US generic portfolio-MYX.AX		28/06/16	2.03MB	Share
MYX	Section 708A notice-MYX.AX		28/06/16	321.75KB	Share
MYX	Appendix 3B-MYX.AX		28/06/16	274.55KB	Share
MYX	MYX announces acquisition of US generic product portfolio-MYX.AX	PRICE SENSITIVE	28/06/16	189.33KB	Share
MYX	Trading Halt-MYX.AX	PRICE SENSITIVE	28/06/16	461.51KB	Share
MYX	MYX receives first generic approval of Tikosyn capsules-MYX.AX	PRICE SENSITIVE	07/06/16	203.54KB	Share
MYX	Wilson HTM Rapid Insights Conference Presentation-MYX.AX		02/06/16	1.21MB	Share
MYX	Change in substantial holding from BTT,BTT-MYX.AX		01/06/16	562.31KB	Share
MYX	Mayne Pharma receives FDA approval for Doryx MPC tablets-MYX.AX	PRICE SENSITIVE	23/05/16	161.16KB	Share

MYX Change of Director's Interest Notice
17/03/17		597.55KB	Share
MYX Ceasing to be a substantial holder
13/03/17		153.53KB	Share
MYX Becoming a substantial holder
09/03/17		268.11KB	Share
MYX Mayne Pharma appoints new Group CFO and Company Secretary
09/03/17		248.49KB	Share
MYX Mayne Pharma acquires rights to generic Duragesic in the US
09/03/17	PRICE SENSITIVE	268.96KB	Share
MYX Change of Director's Interest Notice
08/03/17		596.18KB	Share
MYX Appendix 3B
06/03/17		724.44KB	Share
MYX License and supply agreement for generic Nuvaring in the US
28/02/17	PRICE SENSITIVE	103.27KB	Share
MYX 2017 Half Year Investor Presentation
24/02/17		1.79MB	Share
MYX 2017 Half Year Media Release
24/02/17	PRICE SENSITIVE	312.52KB	Share
MYX Half Yearly Report and Accounts
24/02/17	PRICE SENSITIVE	1.35MB	Share
MYX Appendix 3B
20/02/17		731.15KB	Share
MYX Mayne Pharma launches Butalbital / APAP tablets in the US
16/02/17	PRICE SENSITIVE	246.53KB	Share
MYX Mayne Pharma announces leadership changes
16/01/17		106.72KB	Share
MYX Mayne Pharma launches Amiodarone 100mg tablets
13/01/17	PRICE SENSITIVE	95.19KB	Share
MYX Appendix 3B
12/01/17		316.47KB	Share
MYX Change of Director's Interest Notice
11/01/17		946.66KB	Share
MYX Mayne Pharma launches Fabior and Sorilux in the US
11/01/17	PRICE SENSITIVE	271.31KB	Share
MYX Appendix 3B
28/12/16		324.18KB	Share
MYX Change of Director's Interest Notice
28/12/16		41.9KB	Share
MYX Change of Director's Interest Notice (x4)
21/12/16		1.95MB	Share
MYX Appendix 3B
21/12/16		729.25KB	Share
MYX Change in substantial holding from CBA
21/12/16		537.19KB	Share
MYX Change of Director's Interest Notices (x2)
19/12/16		1.14MB	Share
MYX Update on Status of DOJ Investigation
16/12/16	PRICE SENSITIVE	229.2KB	Share
MYX Change in substantial holding from CBA
13/12/16		1.1MB	Share
MYX Appendix 3B
13/12/16		731.24KB	Share
MYX Change in substantial holding
12/12/16		75.12KB	Share
MYX Change of Director's Interest Notice
12/12/16		49.22KB	Share
MYX Ceasing to be a substantial holder from NAB
12/12/16		173.67KB	Share
MYX Appendix 3B
09/12/16		325.25KB	Share
MYX Change of Director's Interest Notice
07/12/16		41.47KB	Share
MYX Becoming a substantial holder from NAB
30/11/16		564.37KB	Share
MYX Results of Annual General Meeting
29/11/16		241.06KB	Share
MYX 2016 AGM CEO's Speech
29/11/16		209.38KB	Share
MYX 2016 AGM Chairman's Speech
29/11/16		183.9KB	Share
MYX IDT:Mayne Pharma Announces U.S. Launch of IDT's Temozolomide
22/11/16		536.47KB	Share
MYX UBS Australasia Conference Presentation
07/11/16		1.47MB	Share
MYX Update on Status of DOJ Investigation
04/11/16	PRICE SENSITIVE	98.15KB	Share
MYX MYX launches generic MS Contin (morphine sulfate) tablets-MYX.AX
03/11/16	PRICE SENSITIVE	108.48KB	Share
MYX MYX launches generic MS Contin (morphine sulfate) tablets
03/11/16	PRICE SENSITIVE	108.48KB	Share
MYX 1st generic proprietary product shipped to US, temozolomide,MYX-IDT.AX
02/11/16	PRICE SENSITIVE	128.48KB	Share
MYX Becoming a substantial holder from CBA,CBA-MYX.AX
01/11/16		1.18MB	Share
MYX MYX launches generic Entocort EC (Budesonide) capsules-MYX.AX
27/10/16	PRICE SENSITIVE	101.92KB	Share
MYX Notice of Annual General Meeting/Proxy Form-MYX.AX
17/10/16		2.62MB	Share
MYX Appendix 3B-MYX.AX
11/10/16		480.48KB	Share
MYX Appendix 4G-MYX.AX
07/10/16		327.05KB	Share
MYX 2016 Corporate Governance Statement-MYX.AX
07/10/16		395.82KB	Share
MYX 2016 Annual Report-MYX.AX
07/10/16		3.03MB	Share
MYX Appendix 3B-MYX.AX
29/09/16		479.28KB	Share
MYX Ceasing to be a substantial holder from WBC,WBC-MYX.AX
28/09/16		348.18KB	Share
MYX Appendix 3B-MYX.AX
26/09/16		481.27KB	Share
MYX Change of Director's Interest Notice-MYX.AX
23/09/16		108.49KB	Share
MYX Initial Director's Interest Notice-MYX.AX
23/09/16		94.56KB	Share
MYX Mayne Pharma appoints new Board member-MYX.AX
21/09/16		184.86KB	Share
MYX Change of Director's Interest Notice-MYX.AX
13/09/16		386.46KB	Share
MYX Change in substantial holding from WBC,WBC-MYX.AX
01/09/16		695.24KB	Share
MYX Appendix 3B-MYX.AX
28/08/16		480.33KB	Share
MYX 2016 Full Year Results Investor Presentation-MYX.AX
28/08/16		1.2MB	Share
MYX Appendix 4E, Directors Report and Financial Statements-MYX.AX
28/08/16	PRICE SENSITIVE	1.58MB	Share
MYX 2016 Full Year Results Media Release-MYX.AX
28/08/16		238.39KB	Share
MYX 2016 Full Year Results Investor Presentation-MYX.AX
26/08/16		1.2MB	Share
MYX 2016 Full Year Results Media Release-MYX.AX
26/08/16		238.39KB	Share
MYX Appendix 4E, Directors Report and Financial Statements-MYX.AX
26/08/16	PRICE SENSITIVE	1.58MB	Share
MYX Appendix 3B-MYX.AX
25/08/16		480.33KB	Share
MYX Appendix 3B-MYX.AX
22/08/16		479.35KB	Share
MYX Response to ASX Appendix 3Y Query-MYX.AX
19/08/16		718.83KB	Share
MYX Investor Presentation Acquisition of GSK Foam Assets-MYX.AX
18/08/16		855KB	Share
MYX MYX announces acquisition of US foam dermatology assets-MYX.AX
18/08/16	PRICE SENSITIVE	140.14KB	Share
MYX Change of Director's Interest Notice-MYX.AX
16/08/16		312.71KB	Share
MYX Appendix 3B-MYX.AX
11/08/16		479.24KB	Share
MYX Appendix 3B-MYX.AX
04/08/16		478.99KB	Share
MYX Completion of US generic product acquisition from Teva-MYX.AX
03/08/16		107.77KB	Share
MYX MYX announces settlement from patent infringement case-MYX.AX
29/07/16	PRICE SENSITIVE	97.53KB	Share
MYX Change in substantial holding from WBC,WBC-MYX.AX
27/07/16			Share
MYX Change in substantial holding from WBC,WBC-MYX.AX
27/07/16		1.6MB	Share
MYX Change of Director's Interest Notice-MYX.AX
27/07/16		425.38KB	Share
MYX Ceasing to be a substantial holder from BTT,BTT-MYX.AX
26/07/16			Share
MYX Ceasing to be a substantial holder from BTT,BTT-MYX.AX
26/07/16		176.78KB	Share
MYX Appendix 3B-MYX.AX
22/07/16		352.25KB	Share
MYX Change in substantial holding from BTT,BTT-MYX.AX
21/07/16			Share
MYX Change in substantial holding from BTT,BTT-MYX.AX
21/07/16		198.9KB	Share
MYX Retail Entitlement Offer completion and scale back policy-MYX.AX
20/07/16		239.63KB	Share
MYX Change to option exercise price and Appendix 3B-MYX.AX
15/07/16		914.55KB	Share
MYX Change of Director's Interest Notice-MYX.AX
13/07/16		386.6KB	Share
MYX Change of Director's Interest Notices (x5)-MYX.AX
07/07/16		921.63KB	Share
MYX Section 708A notice-MYX.AX
07/07/16		296.85KB	Share
MYX ASX Notice - Accelerated Non Renounceable Entitlement Offer-MYX.AX
06/07/16		364.28KB	Share
MYX Dispatch Retail Offer Booklet and ineligible letter-MYX.AX
05/07/16		404.39KB	Share
MYX Retail Offer Booklet-MYX.AX
30/06/16		6.74MB	Share
MYX Completion institutional entitlement offer and placement-MYX.AX
30/06/16	PRICE SENSITIVE	282.55KB	Share
MYX Investor Presentation Acquisition of US generic portfolio-MYX.AX
28/06/16		2.03MB	Share
MYX Section 708A notice-MYX.AX
28/06/16		321.75KB	Share
MYX Appendix 3B-MYX.AX
28/06/16		274.55KB	Share
MYX MYX announces acquisition of US generic product portfolio-MYX.AX
28/06/16	PRICE SENSITIVE	189.33KB	Share
MYX Trading Halt-MYX.AX
28/06/16	PRICE SENSITIVE	461.51KB	Share
MYX MYX receives first generic approval of Tikosyn capsules-MYX.AX
07/06/16	PRICE SENSITIVE	203.54KB	Share
MYX Wilson HTM Rapid Insights Conference Presentation-MYX.AX
02/06/16		1.21MB	Share
MYX Change in substantial holding from BTT,BTT-MYX.AX
01/06/16		562.31KB	Share
MYX Mayne Pharma receives FDA approval for Doryx MPC tablets-MYX.AX
23/05/16	PRICE SENSITIVE	161.16KB	Share

REFRESH

First 4 5 6 7 8

(20min delay)
Last $4.60		Change -0.170(3.56%)		Mkt cap ! $391.3M

Open	High	Low	Value	Volume
$4.71	$4.73	$4.57	$511.7K	110.1K

Buyers (Bids)

No.	Vol.	Price($)
1	520	$4.60

Sellers (Offers)

Price($)	Vol.	No.
$4.63	562	1

View Market Depth

No.	Vol.	Price($)
1	520	4.600
1	562	4.580
1	562	4.570
1	562	4.560
1	562	4.550

Price($)	Vol.	No.
4.630	562	1
4.640	562	1
4.650	562	1
4.660	562	1
4.700	2498	2

Last trade - 16.10pm 02/10/2024 (20 minute delay)


Last $4.60		Change -0.170 ( 3.23 %)
Open	High	Low	Volume
$4.71	$4.75	$4.57	13482
Last updated 15.59pm 02/10/2024 ?

MYX (ASX) Chart

MAYNE PHARMA GROUP LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories